Waters Corporation Return on Tangible Assets

Return on Tangible Assets of WAT for past 10 years: annual, quarterly and twelve month trailing (TTM) including Return on Tangible Assets growth rates and interactive chart.


Highlights and Quick Summary

  • Annual Return on Tangible Assets for 2020 was 47.85% (a -8.02% decrease from previous year)
  • Annual Return on Tangible Assets for 2019 was 52.02% (a 124.03% increase from previous year)
  • Annual Return on Tangible Assets for 2018 was 23.22% (a 4452.94% increase from previous year)
  • Twelve month Return on Tangible Assets ending December 30, 2020 was 47.85% (a -1.32% decrease compared to previous quarter)
  • Twelve month trailing Return on Tangible Assets increased by 8.41% year-over-year
Trailing Return on Tangible Assets for the last four month:
30 Dec '20 29 Sep '20 29 Jun '20 30 Mar '20
47.85% 48.49% 49.97% 44.14%
Visit stockrow.com/WAT for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Return on Tangible Assets of Waters Corporation

Most recent Return on Tangible Assetsof WAT including historical data for past 10 years.

Interactive Chart of Return on Tangible Assets of Waters Corporation

Waters Corporation Return on Tangible Assets for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 47.85%
2019 52.02%
2018 23.22%
2017 0.51%
2016 15.11%
2015 15.73%
2014 16.87%
2013 18.8%
2012 22.77%
2011 27.45%
2010 26.96%

Business Profile of Waters Corporation

Sector: Healthcare
Industry: Diagnostics & Research
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. Its MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. The company's offers thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company has a collaboration with Genovis AB to develop and market biopharmaceutical characterization workflows based on the its BioAccord LC-MS System, Andrew+ pipetting robot and Genovis SmartEnzymes. Waters Corporation was founded in 1958 and is headquartered in Milford, Massachusetts.